Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.6B | 2.5B | 2.4B |
Cost of revenue | 1.8B | 1.8B | 1.7B | 1.6B |
Gross profit | 863M | 858M | 811M | 804M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 476M | 466M | 448M | 416M |
Other operating expenses | 2M | -6M | 1M | 4M |
Operating income | 346M | 361M | 330M | 355M |
Non operating interest income | ||||
Income | 5M | 7M | 9M | 3M |
Expense | 72M | 72M | 58M | 47M |
Other income expense | -3M | 3M | 15M | 3M |
Pretax income | 276M | 299M | 296M | 314M |
Tax provision | 59M | 68M | 65M | 74M |
Net income | 235M | 236M | 237M | 240M |
Basic EPS | 2.0 | 2.0 | 2.0 | 2.1 |
Diluted EPS | 1.9 | 2.0 | 2.0 | 2.0 |
Basic average shares | 111M | 111M | 112M | 111M |
Diluted average shares | 113M | 113M | 113M | 112M |
EBITDA | 488M | 506M | 479M | 478M |
Net income from continuing op. | 235M | 236M | 237M | 240M |
Minority interests | -15M | -14M | -11M | -11M |
Preferred stock dividends | 1M | 2M | 1M | 1M |